European Cardiovascular Drugs Markets

Table of Contents

1. EXECUTIVE SUMMARY

Overview

• 1. Overview of the European Cardiovascular Drugs Market

2. GLOSSARY OF TERMS

List of Terms

• 1. Abbreviations

3. INTRODUCTION

Disease State Overview

• 1. Disease Description and Risk Factors
• 2. Types of Heart Disease
• 3. Disease Management and Current Treatments

Research Methodology

• 1. Research Methodology for the European Cardiovascular Drugs Market
• 2. Assumptions and Limitations

4. INDUSTRY CHALLENGES

Challenges and Issues

• 1. Challenges Facing the European Cardiovascular Drugs Market

5. MARKET ENGINEERING RESEARCH FOR WORLD CARDIOVASCULAR DRUGS MARKET

World Cardiovascular Drugs Market

• 1. Introduction
• 2. Measurement Analysis
• 3. Revenue Forecasts
• 4. Trends by Geographic Regions
• 5. Segment Analysis

6. MARKET ENGINEERING RESEARCH FOR EUROPEAN CARDIOVASCULAR DRUGS MARKET

European Cardiovascular Drugs Market

• 1. Introduction and Market Segmentation
• 2. Measurements Analysis
• 3. Key Market Drivers
• 4. Key Market Restraints
• 5. Revenue Forecasts
• 6. Segment-wise Analysis

7. CARDIOVASCULAR DRUGS MARKET IN THE UNITED KINGDOM

Research

• 1. Market Overview
• 2. Revenue Forecasts

8. CARDIOVASCULAR DRUGS MARKET IN GERMANY

Research

• 1. Market Overview
• 2. Revenue Forecasts

9. CARDIOVASCULAR DRUGS MARKET IN FRANCE

Research

• 1. Market Overview
• 2. Revenue Forecasts

10. CARDIOVASCULAR DRUGS MARKET IN ITALY

Research

• 1. Market Overview
• 2. Revenue Forecasts

11. CARDIOVASCULAR DRUGS MARKET IN SPAIN

Research

• 1. Market Overview
• 2. Revenue Forecasts

12. PORTFOLIO ANALYSIS

Company Profiles and Product Pipeline

• 1. AstraZeneca
• 2. Bristol-Myers Squibb
• 3. Merck & Co. Inc
• 4. Novartis
• 5. Pfizer
• 6. Sanofi-Aventis

13. STRATEGIC RECOMMENDATIONS

Recommendations

• 1. Strategic Recommendations for the European Cardiovascular Drugs Market

14. DATABASE OF KEY INDUSTRY PARTICIPANTS

Key Industry Participants

• 1. Major Participants

15. DECISION SUPPORT DATABASES

Cardiovascular Diseases

• 1. Cardiovascular Prevalence
• 2. Percent of Cardiovascular Disease Prevalence
• 3. Prevalence of Hypertension
• 4. Prevalence of Hypertension as Percentage of Population
• 5. Incidence of Myocardial Infarction
• 6. Incidence of Stroke
• 7. Mortality due to Coronary Heart Disease
• 8. Mortality due to Circulatory Disease
• 9. Mortality due to Chronic Rheumatic Heart Disease
• 10. Heart Attack Mortality
• 11. Mortality due to Hypertensive Diseases